Copyright
©The Author(s) 2015.
World J Gastroenterol. Aug 28, 2015; 21(32): 9598-9606
Published online Aug 28, 2015. doi: 10.3748/wjg.v21.i32.9598
Published online Aug 28, 2015. doi: 10.3748/wjg.v21.i32.9598
Figure 2 Changes between post- and pre-treatment Ishak fibrosis scores for all patients in the entecavir and lamivudine arms.
The blue columns indicate patients with improvement, and pink columns indicate progression. The scales indicate no change. ETV: Entecavir; LAM: Lamivudine.
-
Citation: Wang JL, Du XF, Chen SL, Yu YQ, Wang J, Hu XQ, Shao LY, Chen JZ, Weng XH, Zhang WH. Histological outcome for chronic hepatitis B patients treated with entecavir
vs lamivudine-based therapy. World J Gastroenterol 2015; 21(32): 9598-9606 - URL: https://www.wjgnet.com/1007-9327/full/v21/i32/9598.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i32.9598